Alembic announces USFDA tentative approval for Selexipag for Injection, 1,800 mcg/vial
Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
Sacubitril and Valsartan combination is used to treat chronic heart failure in adults
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Dyslipidemia is a critical risk factor for cardiovascular diseases
States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika
Dr. Sanjay Behari, Director of Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, as the President of the Medical Assessment and Rating Board
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
Subscribe To Our Newsletter & Stay Updated